Global Scalp Care Treatment Market

Scalp Care Treatment Comprehensive Study by Type (Medicated, Non-Medicated), Drug Type (Branded, Generics), Distribution Channel (Supermarket, Specialty Store, Pharmacy Store, Conventional Stores, Online Stores, Others), Age Group (Adults, Pediatrics, Neonates), Problem (Fungal Dandruff, Dry Scalp, Oily Scalp, Disease due to Dandruff, Others), End User (Homecare, Dermatology, Specialty Clinics, Salon, Others) Players and Region - Global Market Outlook to 2027

Scalp Care Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Scalp Care Treatment help in the protection and nourishment of the Scalp, as well as the reduction of hair damage. Scalp care treatment improves the texture and quality of hair to keep it healthy. Exfoliation, cleansing, and moisturizing are all important for the scalp's health. Shampooing alone is insufficient to remove buildup from styling products, oil, pollutants, and perspiration from the scalp.
This growth is primarily driven by Increasing Awareness Regarding Healthy Scalp due to Environmental Change and Availability of Various Scalp Treatment Products.

Globally, a noticeable market trend is evident Technology Improvement in Various Innovative Scalp Treatment Products and Rising Disposable Income. Major Players, such as Malin and Goetz (United States), Ameliorate Laboratories (United Kingdom), The Inkey List (United Kingdom), Drunk Elephant (United States), Unilever (United Kingdom), L’Oreal (United States), Aveda (United States), Kerastase (France), Virtue (United States), Philip Kingsley (United Kingdom), Mauli Rituals (United Kingdom), Living Proof (United States), Sisley-Paris (France) and Kreyòl Essence (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

On 12 March 2021, Living Proof launch Dry Scalp Treatment and Revitalizing treatment. The Scalp Care Rejuvenating Treatment, a Revitalizing elixir with the juice itself. It also comes with the product and neatly tucks into the bottle. It comes with a clever applicator to administer the lotion directly at the roots while offering a lovely small massage. The scalp collection focuses on both short-term scalp comfort and increased hair thickness, as well as long-term advantages centered on a new unique formula for a healthier scalp overall. The scalp treatment product will give thicker, fuller-looking hair from the root.

Regulatory Insights:
“As per USFDA, Department of Health and Human Services a condition in which the scalp's dead epidermal cells shed at a faster pace. Irritation, itching, redness, and excessive shedding of dead epidermal cells define this scalp or body disease. Selenium sulfide is a finely ground product with a median particle size of around 5 micrometers ([micro]m) and less than 0.1 percent. When a coal tar solution, derivative, or fraction is used as a source of coal tar, the labeling must state the identity and concentration of the coal tar source utilized, as well as the concentration of coal tar in the finished product.”

Market Drivers
  • Increasing Awareness Regarding Healthy Scalp due to Environmental Change
  • Availability of Various Scalp Treatment Products

Market Trend
  • Technology Improvement in Various Innovative Scalp Treatment Products and Rising Disposable Income

Restraints
  • Changes of Infection and Redness on Scalp and Hair Fall Problem Due to Excess Use of Scalp Treatment Products

Opportunities
Increasing Scalp Problems and Advertisement of Scalp Treatment Products will boost the Scalp Care Treatment Market and Treatment Products come with the Blend of Vitamin B, Peptides, Prebiotics, and Alpha Keratin will grow the Scalp Care Treatment Market
Challenges
Use of Harsh Chemical Such as Sulfate, Paraben, Sodium Lauryl Sulfate in Treatment Products Can hamper the Scalp Care Treatment Market

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Scalp Care Treatment Study Sheds Light on
— The Scalp Care Treatment Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Scalp Care Treatment industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Scalp Care Treatment industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Medicated
  • Non-Medicated
By Drug Type
  • Branded
  • Generics

By Distribution Channel
  • Supermarket
  • Specialty Store
  • Pharmacy Store
  • Conventional Stores
  • Online Stores
  • Others

By Age Group
  • Adults
  • Pediatrics
  • Neonates

By Problem
  • Fungal Dandruff
  • Dry Scalp
  • Oily Scalp
  • Disease due to Dandruff
  • Others

By End User
  • Homecare
  • Dermatology
  • Specialty Clinics
  • Salon
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness Regarding Healthy Scalp due to Environmental Change
      • 3.2.2. Availability of Various Scalp Treatment Products
    • 3.3. Market Challenges
      • 3.3.1. Use of Harsh Chemical Such as Sulfate, Paraben, Sodium Lauryl Sulfate in Treatment Products Can hamper the Scalp Care Treatment Market
    • 3.4. Market Trends
      • 3.4.1. Technology Improvement in Various Innovative Scalp Treatment Products and Rising Disposable Income
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Scalp Care Treatment, by Type, Drug Type, Distribution Channel, Age Group, Problem, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Scalp Care Treatment (Value)
      • 5.2.1. Global Scalp Care Treatment by: Type (Value)
        • 5.2.1.1. Medicated
        • 5.2.1.2. Non-Medicated
      • 5.2.2. Global Scalp Care Treatment by: Drug Type (Value)
        • 5.2.2.1. Branded
        • 5.2.2.2. Generics
      • 5.2.3. Global Scalp Care Treatment by: Distribution Channel (Value)
        • 5.2.3.1. Supermarket
        • 5.2.3.2. Specialty Store
        • 5.2.3.3. Pharmacy Store
        • 5.2.3.4. Conventional Stores
        • 5.2.3.5. Online Stores
        • 5.2.3.6. Others
      • 5.2.4. Global Scalp Care Treatment by: Age Group (Value)
        • 5.2.4.1. Adults
        • 5.2.4.2. Pediatrics
        • 5.2.4.3. Neonates
      • 5.2.5. Global Scalp Care Treatment by: Problem (Value)
        • 5.2.5.1. Fungal Dandruff
        • 5.2.5.2. Dry Scalp
        • 5.2.5.3. Oily Scalp
        • 5.2.5.4. Disease due to Dandruff
        • 5.2.5.5. Others
      • 5.2.6. Global Scalp Care Treatment by: End User (Value)
        • 5.2.6.1. Homecare
        • 5.2.6.2. Dermatology
        • 5.2.6.3. Specialty Clinics
        • 5.2.6.4. Salon
        • 5.2.6.5. Others
      • 5.2.7. Global Scalp Care Treatment Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Scalp Care Treatment (Price)
      • 5.3.1. Global Scalp Care Treatment by: Type (Price)
  • 6. Scalp Care Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Malin and Goetz (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ameliorate Laboratories (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. The Inkey List (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Drunk Elephant (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Unilever (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. L’Oreal (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Aveda (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kerastase (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Virtue (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Philip Kingsley (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Mauli Rituals (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Living Proof (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Sisley-Paris (France)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Kreyòl Essence (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Scalp Care Treatment Sale, by Type, Drug Type, Distribution Channel, Age Group, Problem, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Scalp Care Treatment (Value)
      • 7.2.1. Global Scalp Care Treatment by: Type (Value)
        • 7.2.1.1. Medicated
        • 7.2.1.2. Non-Medicated
      • 7.2.2. Global Scalp Care Treatment by: Drug Type (Value)
        • 7.2.2.1. Branded
        • 7.2.2.2. Generics
      • 7.2.3. Global Scalp Care Treatment by: Distribution Channel (Value)
        • 7.2.3.1. Supermarket
        • 7.2.3.2. Specialty Store
        • 7.2.3.3. Pharmacy Store
        • 7.2.3.4. Conventional Stores
        • 7.2.3.5. Online Stores
        • 7.2.3.6. Others
      • 7.2.4. Global Scalp Care Treatment by: Age Group (Value)
        • 7.2.4.1. Adults
        • 7.2.4.2. Pediatrics
        • 7.2.4.3. Neonates
      • 7.2.5. Global Scalp Care Treatment by: Problem (Value)
        • 7.2.5.1. Fungal Dandruff
        • 7.2.5.2. Dry Scalp
        • 7.2.5.3. Oily Scalp
        • 7.2.5.4. Disease due to Dandruff
        • 7.2.5.5. Others
      • 7.2.6. Global Scalp Care Treatment by: End User (Value)
        • 7.2.6.1. Homecare
        • 7.2.6.2. Dermatology
        • 7.2.6.3. Specialty Clinics
        • 7.2.6.4. Salon
        • 7.2.6.5. Others
      • 7.2.7. Global Scalp Care Treatment Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Scalp Care Treatment (Price)
      • 7.3.1. Global Scalp Care Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Scalp Care Treatment: by Type(USD N)
  • Table 2. Scalp Care Treatment Medicated , by Region USD N (2016-2021)
  • Table 3. Scalp Care Treatment Non-Medicated , by Region USD N (2016-2021)
  • Table 4. Scalp Care Treatment: by Drug Type(USD N)
  • Table 5. Scalp Care Treatment Branded , by Region USD N (2016-2021)
  • Table 6. Scalp Care Treatment Generics , by Region USD N (2016-2021)
  • Table 7. Scalp Care Treatment: by Distribution Channel(USD N)
  • Table 8. Scalp Care Treatment Supermarket , by Region USD N (2016-2021)
  • Table 9. Scalp Care Treatment Specialty Store , by Region USD N (2016-2021)
  • Table 10. Scalp Care Treatment Pharmacy Store , by Region USD N (2016-2021)
  • Table 11. Scalp Care Treatment Conventional Stores , by Region USD N (2016-2021)
  • Table 12. Scalp Care Treatment Online Stores , by Region USD N (2016-2021)
  • Table 13. Scalp Care Treatment Others , by Region USD N (2016-2021)
  • Table 14. Scalp Care Treatment: by Age Group(USD N)
  • Table 15. Scalp Care Treatment Adults , by Region USD N (2016-2021)
  • Table 16. Scalp Care Treatment Pediatrics , by Region USD N (2016-2021)
  • Table 17. Scalp Care Treatment Neonates , by Region USD N (2016-2021)
  • Table 18. Scalp Care Treatment: by Problem(USD N)
  • Table 19. Scalp Care Treatment Fungal Dandruff , by Region USD N (2016-2021)
  • Table 20. Scalp Care Treatment Dry Scalp , by Region USD N (2016-2021)
  • Table 21. Scalp Care Treatment Oily Scalp , by Region USD N (2016-2021)
  • Table 22. Scalp Care Treatment Disease due to Dandruff , by Region USD N (2016-2021)
  • Table 23. Scalp Care Treatment Others , by Region USD N (2016-2021)
  • Table 24. Scalp Care Treatment: by End User(USD N)
  • Table 25. Scalp Care Treatment Homecare , by Region USD N (2016-2021)
  • Table 26. Scalp Care Treatment Dermatology , by Region USD N (2016-2021)
  • Table 27. Scalp Care Treatment Specialty Clinics , by Region USD N (2016-2021)
  • Table 28. Scalp Care Treatment Salon , by Region USD N (2016-2021)
  • Table 29. Scalp Care Treatment Others , by Region USD N (2016-2021)
  • Table 30. South America Scalp Care Treatment, by Country USD N (2016-2021)
  • Table 31. South America Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 32. South America Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 33. South America Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 34. South America Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 35. South America Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 36. South America Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 37. Brazil Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 38. Brazil Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 39. Brazil Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 40. Brazil Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 41. Brazil Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 42. Brazil Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 43. Argentina Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 44. Argentina Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 45. Argentina Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 46. Argentina Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 47. Argentina Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 48. Argentina Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 49. Rest of South America Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 50. Rest of South America Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 51. Rest of South America Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 52. Rest of South America Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 53. Rest of South America Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 54. Rest of South America Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 55. Asia Pacific Scalp Care Treatment, by Country USD N (2016-2021)
  • Table 56. Asia Pacific Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 57. Asia Pacific Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 58. Asia Pacific Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 59. Asia Pacific Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 60. Asia Pacific Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 61. Asia Pacific Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 62. China Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 63. China Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 64. China Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 65. China Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 66. China Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 67. China Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 68. Japan Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 69. Japan Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 70. Japan Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 71. Japan Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 72. Japan Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 73. Japan Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 74. India Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 75. India Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 76. India Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 77. India Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 78. India Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 79. India Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 80. South Korea Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 81. South Korea Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 82. South Korea Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 83. South Korea Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 84. South Korea Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 85. South Korea Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 86. Taiwan Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 87. Taiwan Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 88. Taiwan Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 89. Taiwan Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 90. Taiwan Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 91. Taiwan Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 92. Australia Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 93. Australia Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 94. Australia Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 95. Australia Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 96. Australia Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 97. Australia Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 98. Rest of Asia-Pacific Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 99. Rest of Asia-Pacific Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 100. Rest of Asia-Pacific Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 101. Rest of Asia-Pacific Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 102. Rest of Asia-Pacific Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 103. Rest of Asia-Pacific Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 104. Europe Scalp Care Treatment, by Country USD N (2016-2021)
  • Table 105. Europe Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 106. Europe Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 107. Europe Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 108. Europe Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 109. Europe Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 110. Europe Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 111. Germany Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 112. Germany Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 113. Germany Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 114. Germany Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 115. Germany Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 116. Germany Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 117. France Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 118. France Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 119. France Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 120. France Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 121. France Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 122. France Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 123. Italy Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 124. Italy Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 125. Italy Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 126. Italy Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 127. Italy Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 128. Italy Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 129. United Kingdom Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 130. United Kingdom Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 131. United Kingdom Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 132. United Kingdom Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 133. United Kingdom Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 134. United Kingdom Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 135. Netherlands Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 136. Netherlands Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 137. Netherlands Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 138. Netherlands Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 139. Netherlands Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 140. Netherlands Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 141. Rest of Europe Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 142. Rest of Europe Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 143. Rest of Europe Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 144. Rest of Europe Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 145. Rest of Europe Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 146. Rest of Europe Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 147. MEA Scalp Care Treatment, by Country USD N (2016-2021)
  • Table 148. MEA Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 149. MEA Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 150. MEA Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 151. MEA Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 152. MEA Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 153. MEA Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 154. Middle East Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 155. Middle East Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 156. Middle East Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 157. Middle East Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 158. Middle East Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 159. Middle East Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 160. Africa Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 161. Africa Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 162. Africa Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 163. Africa Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 164. Africa Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 165. Africa Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 166. North America Scalp Care Treatment, by Country USD N (2016-2021)
  • Table 167. North America Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 168. North America Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 169. North America Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 170. North America Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 171. North America Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 172. North America Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 173. United States Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 174. United States Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 175. United States Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 176. United States Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 177. United States Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 178. United States Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 179. Canada Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 180. Canada Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 181. Canada Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 182. Canada Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 183. Canada Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 184. Canada Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 185. Mexico Scalp Care Treatment, by Type USD N (2016-2021)
  • Table 186. Mexico Scalp Care Treatment, by Drug Type USD N (2016-2021)
  • Table 187. Mexico Scalp Care Treatment, by Distribution Channel USD N (2016-2021)
  • Table 188. Mexico Scalp Care Treatment, by Age Group USD N (2016-2021)
  • Table 189. Mexico Scalp Care Treatment, by Problem USD N (2016-2021)
  • Table 190. Mexico Scalp Care Treatment, by End User USD N (2016-2021)
  • Table 191. Scalp Care Treatment: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Scalp Care Treatment: by Type(USD N)
  • Table 207. Scalp Care Treatment Medicated , by Region USD N (2022-2027)
  • Table 208. Scalp Care Treatment Non-Medicated , by Region USD N (2022-2027)
  • Table 209. Scalp Care Treatment: by Drug Type(USD N)
  • Table 210. Scalp Care Treatment Branded , by Region USD N (2022-2027)
  • Table 211. Scalp Care Treatment Generics , by Region USD N (2022-2027)
  • Table 212. Scalp Care Treatment: by Distribution Channel(USD N)
  • Table 213. Scalp Care Treatment Supermarket , by Region USD N (2022-2027)
  • Table 214. Scalp Care Treatment Specialty Store , by Region USD N (2022-2027)
  • Table 215. Scalp Care Treatment Pharmacy Store , by Region USD N (2022-2027)
  • Table 216. Scalp Care Treatment Conventional Stores , by Region USD N (2022-2027)
  • Table 217. Scalp Care Treatment Online Stores , by Region USD N (2022-2027)
  • Table 218. Scalp Care Treatment Others , by Region USD N (2022-2027)
  • Table 219. Scalp Care Treatment: by Age Group(USD N)
  • Table 220. Scalp Care Treatment Adults , by Region USD N (2022-2027)
  • Table 221. Scalp Care Treatment Pediatrics , by Region USD N (2022-2027)
  • Table 222. Scalp Care Treatment Neonates , by Region USD N (2022-2027)
  • Table 223. Scalp Care Treatment: by Problem(USD N)
  • Table 224. Scalp Care Treatment Fungal Dandruff , by Region USD N (2022-2027)
  • Table 225. Scalp Care Treatment Dry Scalp , by Region USD N (2022-2027)
  • Table 226. Scalp Care Treatment Oily Scalp , by Region USD N (2022-2027)
  • Table 227. Scalp Care Treatment Disease due to Dandruff , by Region USD N (2022-2027)
  • Table 228. Scalp Care Treatment Others , by Region USD N (2022-2027)
  • Table 229. Scalp Care Treatment: by End User(USD N)
  • Table 230. Scalp Care Treatment Homecare , by Region USD N (2022-2027)
  • Table 231. Scalp Care Treatment Dermatology , by Region USD N (2022-2027)
  • Table 232. Scalp Care Treatment Specialty Clinics , by Region USD N (2022-2027)
  • Table 233. Scalp Care Treatment Salon , by Region USD N (2022-2027)
  • Table 234. Scalp Care Treatment Others , by Region USD N (2022-2027)
  • Table 235. South America Scalp Care Treatment, by Country USD N (2022-2027)
  • Table 236. South America Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 237. South America Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 238. South America Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 239. South America Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 240. South America Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 241. South America Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 242. Brazil Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 243. Brazil Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 244. Brazil Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 245. Brazil Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 246. Brazil Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 247. Brazil Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 248. Argentina Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 249. Argentina Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 250. Argentina Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 251. Argentina Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 252. Argentina Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 253. Argentina Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 254. Rest of South America Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 255. Rest of South America Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 256. Rest of South America Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 257. Rest of South America Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 258. Rest of South America Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 259. Rest of South America Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 260. Asia Pacific Scalp Care Treatment, by Country USD N (2022-2027)
  • Table 261. Asia Pacific Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 262. Asia Pacific Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 263. Asia Pacific Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 264. Asia Pacific Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 265. Asia Pacific Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 266. Asia Pacific Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 267. China Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 268. China Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 269. China Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 270. China Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 271. China Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 272. China Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 273. Japan Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 274. Japan Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 275. Japan Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 276. Japan Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 277. Japan Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 278. Japan Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 279. India Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 280. India Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 281. India Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 282. India Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 283. India Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 284. India Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 285. South Korea Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 286. South Korea Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 287. South Korea Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 288. South Korea Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 289. South Korea Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 290. South Korea Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 291. Taiwan Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 292. Taiwan Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 293. Taiwan Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 294. Taiwan Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 295. Taiwan Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 296. Taiwan Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 297. Australia Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 298. Australia Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 299. Australia Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 300. Australia Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 301. Australia Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 302. Australia Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 303. Rest of Asia-Pacific Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 304. Rest of Asia-Pacific Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 305. Rest of Asia-Pacific Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 306. Rest of Asia-Pacific Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 307. Rest of Asia-Pacific Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 308. Rest of Asia-Pacific Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 309. Europe Scalp Care Treatment, by Country USD N (2022-2027)
  • Table 310. Europe Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 311. Europe Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 312. Europe Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 313. Europe Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 314. Europe Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 315. Europe Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 316. Germany Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 317. Germany Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 318. Germany Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 319. Germany Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 320. Germany Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 321. Germany Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 322. France Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 323. France Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 324. France Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 325. France Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 326. France Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 327. France Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 328. Italy Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 329. Italy Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 330. Italy Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 331. Italy Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 332. Italy Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 333. Italy Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 334. United Kingdom Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 335. United Kingdom Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 336. United Kingdom Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 337. United Kingdom Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 338. United Kingdom Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 339. United Kingdom Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 340. Netherlands Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 341. Netherlands Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 342. Netherlands Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 343. Netherlands Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 344. Netherlands Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 345. Netherlands Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 346. Rest of Europe Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 347. Rest of Europe Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 348. Rest of Europe Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 349. Rest of Europe Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 350. Rest of Europe Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 351. Rest of Europe Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 352. MEA Scalp Care Treatment, by Country USD N (2022-2027)
  • Table 353. MEA Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 354. MEA Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 355. MEA Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 356. MEA Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 357. MEA Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 358. MEA Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 359. Middle East Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 360. Middle East Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 361. Middle East Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 362. Middle East Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 363. Middle East Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 364. Middle East Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 365. Africa Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 366. Africa Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 367. Africa Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 368. Africa Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 369. Africa Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 370. Africa Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 371. North America Scalp Care Treatment, by Country USD N (2022-2027)
  • Table 372. North America Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 373. North America Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 374. North America Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 375. North America Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 376. North America Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 377. North America Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 378. United States Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 379. United States Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 380. United States Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 381. United States Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 382. United States Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 383. United States Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 384. Canada Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 385. Canada Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 386. Canada Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 387. Canada Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 388. Canada Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 389. Canada Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 390. Mexico Scalp Care Treatment, by Type USD N (2022-2027)
  • Table 391. Mexico Scalp Care Treatment, by Drug Type USD N (2022-2027)
  • Table 392. Mexico Scalp Care Treatment, by Distribution Channel USD N (2022-2027)
  • Table 393. Mexico Scalp Care Treatment, by Age Group USD N (2022-2027)
  • Table 394. Mexico Scalp Care Treatment, by Problem USD N (2022-2027)
  • Table 395. Mexico Scalp Care Treatment, by End User USD N (2022-2027)
  • Table 396. Scalp Care Treatment: by Type(USD/Units)
  • Table 397. Research Programs/Design for This Report
  • Table 398. Key Data Information from Secondary Sources
  • Table 399. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Scalp Care Treatment: by Type USD N (2016-2021)
  • Figure 5. Global Scalp Care Treatment: by Drug Type USD N (2016-2021)
  • Figure 6. Global Scalp Care Treatment: by Distribution Channel USD N (2016-2021)
  • Figure 7. Global Scalp Care Treatment: by Age Group USD N (2016-2021)
  • Figure 8. Global Scalp Care Treatment: by Problem USD N (2016-2021)
  • Figure 9. Global Scalp Care Treatment: by End User USD N (2016-2021)
  • Figure 10. South America Scalp Care Treatment Share (%), by Country
  • Figure 11. Asia Pacific Scalp Care Treatment Share (%), by Country
  • Figure 12. Europe Scalp Care Treatment Share (%), by Country
  • Figure 13. MEA Scalp Care Treatment Share (%), by Country
  • Figure 14. North America Scalp Care Treatment Share (%), by Country
  • Figure 15. Global Scalp Care Treatment: by Type USD/Units (2016-2021)
  • Figure 16. Global Scalp Care Treatment share by Players 2021 (%)
  • Figure 17. Global Scalp Care Treatment share by Players (Top 3) 2021(%)
  • Figure 18. Global Scalp Care Treatment share by Players (Top 5) 2021(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. Malin and Goetz (United States) Revenue, Net Income and Gross profit
  • Figure 21. Malin and Goetz (United States) Revenue: by Geography 2021
  • Figure 22. Ameliorate Laboratories (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. Ameliorate Laboratories (United Kingdom) Revenue: by Geography 2021
  • Figure 24. The Inkey List (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. The Inkey List (United Kingdom) Revenue: by Geography 2021
  • Figure 26. Drunk Elephant (United States) Revenue, Net Income and Gross profit
  • Figure 27. Drunk Elephant (United States) Revenue: by Geography 2021
  • Figure 28. Unilever (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Unilever (United Kingdom) Revenue: by Geography 2021
  • Figure 30. L’Oreal (United States) Revenue, Net Income and Gross profit
  • Figure 31. L’Oreal (United States) Revenue: by Geography 2021
  • Figure 32. Aveda (United States) Revenue, Net Income and Gross profit
  • Figure 33. Aveda (United States) Revenue: by Geography 2021
  • Figure 34. Kerastase (France) Revenue, Net Income and Gross profit
  • Figure 35. Kerastase (France) Revenue: by Geography 2021
  • Figure 36. Virtue (United States) Revenue, Net Income and Gross profit
  • Figure 37. Virtue (United States) Revenue: by Geography 2021
  • Figure 38. Philip Kingsley (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 39. Philip Kingsley (United Kingdom) Revenue: by Geography 2021
  • Figure 40. Mauli Rituals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 41. Mauli Rituals (United Kingdom) Revenue: by Geography 2021
  • Figure 42. Living Proof (United States) Revenue, Net Income and Gross profit
  • Figure 43. Living Proof (United States) Revenue: by Geography 2021
  • Figure 44. Sisley-Paris (France) Revenue, Net Income and Gross profit
  • Figure 45. Sisley-Paris (France) Revenue: by Geography 2021
  • Figure 46. Kreyòl Essence (United States) Revenue, Net Income and Gross profit
  • Figure 47. Kreyòl Essence (United States) Revenue: by Geography 2021
  • Figure 48. Global Scalp Care Treatment: by Type USD N (2022-2027)
  • Figure 49. Global Scalp Care Treatment: by Drug Type USD N (2022-2027)
  • Figure 50. Global Scalp Care Treatment: by Distribution Channel USD N (2022-2027)
  • Figure 51. Global Scalp Care Treatment: by Age Group USD N (2022-2027)
  • Figure 52. Global Scalp Care Treatment: by Problem USD N (2022-2027)
  • Figure 53. Global Scalp Care Treatment: by End User USD N (2022-2027)
  • Figure 54. South America Scalp Care Treatment Share (%), by Country
  • Figure 55. Asia Pacific Scalp Care Treatment Share (%), by Country
  • Figure 56. Europe Scalp Care Treatment Share (%), by Country
  • Figure 57. MEA Scalp Care Treatment Share (%), by Country
  • Figure 58. North America Scalp Care Treatment Share (%), by Country
  • Figure 59. Global Scalp Care Treatment: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Malin and Goetz (United States)
  • Ameliorate Laboratories (United Kingdom)
  • The Inkey List (United Kingdom)
  • Drunk Elephant (United States)
  • Unilever (United Kingdom)
  • L’Oreal (United States)
  • Aveda (United States)
  • Kerastase (France)
  • Virtue (United States)
  • Philip Kingsley (United Kingdom)
  • Mauli Rituals (United Kingdom)
  • Living Proof (United States)
  • Sisley-Paris (France)
  • Kreyòl Essence (United States)
Additional players considered in the study are as follows:
Shiseido (Japan) , Amorepacific (South Korea) , Kao (Japan)
Select User Access Type

Key Highlights of Report


Mar 2022 205 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Scalp Care Treatment Market Quantitative research analysis
Global Scalp Care Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Scalp Care Treatment market is expected to see a CAGR of % during projected year 2021 to 2027.
Top performing companies in the Global Scalp Care Treatment market are Malin and Goetz (United States), Ameliorate Laboratories (United Kingdom), The Inkey List (United Kingdom), Drunk Elephant (United States), Unilever (United Kingdom), L’Oreal (United States), Aveda (United States), Kerastase (France), Virtue (United States), Philip Kingsley (United Kingdom), Mauli Rituals (United Kingdom), Living Proof (United States), Sisley-Paris (France) and Kreyòl Essence (United States), to name a few.
is dominating the Scalp Care Treatment Market.

Know More About Global Scalp Care Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Stool Softeners Comprehensive Study by Type (Soft gel capsules, Oral liquids, Tablet, Chewable, Flake, Powder, Others), Distribution Channel (Pharmacy Stores, Online Stores, Hospitals, Clinics, Other...
$ 3450
Coccidiosis Treatment Comprehensive Study by Type (Sulfadimethoxine, Sulfaguanidine, Furazolidone, Trimethoprim/Sulfonamide, Others), Application (Poultry, Dog, Fish, Cat, Cattle, Others), Consumptio...
$ 3450
Scleroderma Therapy Comprehensive Study by Type (Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues,...
$ 3650
Vaccine Shippers Comprehensive Study by Type (Insulated Shippers, Insulated Containers, Refrigerants), Application (Pharma, Biopharma), Type (Active Systems, Passive Systems), Usability Type (Single,...
$ 3500
Serum Lactate Testing Comprehensive Study by Application (Hospitals, Clinics, Home Care, Others), Indication (Sepsis, Heart attack, Congestive heart failure, Respiratory failure, Severe Anaemia Liver...
$ 3750
5HT3 Receptor Antagonists Comprehensive Study by Type (Ondansetron, Granisetron, Dolasetron, Palonosetron), Indication (Post-Operative Induced Nausea and Vomiting, Radiation-Induced Nausea and Vomiti...
$ 3750